Congratulations to Sol-Gel Technologies, a clinical-stage dermatology company, on its US $22.8 million concurrent registered direct and private placement offerings.
Representing Sol-Gel Technologies in the successful transaction – Partner Perry Wildes of the Capital Markets Department, Partner Tami Fishman Jutkowitz of the Healthcare and Life Sciences Department, Atty. Sherine Badarnah of the Hi-Tech and Venture Capital Department, and Intern Eylon Goldberg from the Hi-Tech and Venture Capital Department.
